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Abstract
Background
Dual processing models of psychopathology emphasize the relevance of differentiating
between deliberative self-evaluative processes (explicit self-esteem; ESE) and automati-
cally-elicited affective self-associations (implicit self-esteem; ISE). It has been proposed
that both low ESE and ISE would be involved in major depressive disorder (MDD) and anxi-
ety disorders (AD). Further, it has been hypothesized that MDD and AD may result in a low
ISE “scar” that may contribute to recurrence after remission. However, the available evi-
dence provides no straightforward support for the relevance of low ISE in MDD/AD, and
studies testing the relevance of discrepant SE even showed that especially high ISE com-
bined with low ESE is predictive of the development of internalizing symptoms. However,
these earlier findings have been limited by small sample sizes, poorly defined groups in
terms of comorbidity and phase of the disorders, and by using inadequate indices of discrep-
ant SE. Therefore, this study tested further the proposed role of ISE and discrepant SE in a
large-scale study allowing for stricter differentiation between groups and phase of disorder.
Method
In the context of the Netherlands Study of Depression and Anxiety (NESDA), we selected
participants with current MDD (n = 60), AD (n = 111), and comorbid MDD/AD (n = 71), remit-
ted MDD (n = 41), AD (n = 29), and comorbid MDD/AD (n = 14), recovered MDD (n = 136)
and AD (n = 98), and never MDD or AD controls (n = 382). The Implicit Association Test was
used to index ISE and the Rosenberg Self-Esteem Scale indexed ESE.
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Results
Controls reported higher ESE than all other groups, and current comorbid MDD/AD had
lower ESE than all other clinical groups. ISE was only lower than controls in current comor-
bid AD/MDD. Discrepant self-esteem (difference between ISE and ESE) was not associated
with disorder status once controlling for ESE.
Limitations
Cross-sectional design limits causal inferences.
Conclusion
Findings suggest a prominent role for ESE in MDD and AD, while in comorbid MDD/AD neg-
ative self-evaluations are also present at the implicit level. There was no evidence to support
the view that AD and MDD would result in a low ISE “scar”.
Introduction
Self-reported low self-esteem has consistently been observed in episodes of major depressive
disorder(MDD; [1]) and in episodes of anxiety disorders (AD; [2]) like social anxiety disorder,
panic disorder, and generalized anxiety disorder. It is unsurprising that low self-esteem is prev-
alent in MDD given that it is one of the possible symptoms as outlined in the most recent ver-
sion of the Diagnostic and Statistical Manual of Mental Disorders (“feelings of worthlessness”;
[3]). In a meta-analysis [4], low self-esteem was shown to predict prospective symptoms of
depression and anxiety, highlighting a potential causal role in MDD and AD etiology. The
authors argued that low self-esteem might lead to social disruptions, increased self-focus, and
rumination, which would in turn lead to the development (and maintenance) of depressive
symptoms. For symptoms of anxiety, high self-esteem has been argued to act as an anxiety
buffer [5], and therefore low levels of self-esteem would make an individual more vulnerable
to anxious thoughts and feelings. Indeed, those who had been manipulated with a self-esteem
boost reported less anxiety following a traumatic video than those who had received a neutral
self-esteem manipulation [5]. As such, the presence and relevance of low self-esteem in both
AD and MDD is fairly indisputable. In the present article, we use the term “episode” also for
the duration that a person meets the criteria for an AD without recovery.
Self-esteem has been predominantly indexed by self-report measures, which are limited by
what the respondent is willing and able to disclose (e.g., [6,7]). Meanwhile, relevant self-associ-
ations may not necessarily be accessible for conscious introspection, and individuals may dis-
miss certain initial associations as irrelevant when asked to verbalize a global affective self-
evaluation. This points to the importance of complementing self-report measures reflecting
the “self-endorsed”, deliberate self-evaluations (explicit self-esteem; [8]) with measures of
automatic associations that require neither verbalization nor introspection (implicit self-
esteem; cf. [9]). The relevance of differentiating between explicit (ESE) and implicit self-esteem
(ISE) is further emphasized by the view that both facets of self-esteem are differentially
involved in more controlled/strategic versus more automatic/spontaneous behaviors. ESE is
considered to be especially relevant in the context of more deliberative/reflective behavior
(e.g., choosing not to speak up in a group discussion), while ISE is argued to be critically
involved in more reflexive, spontaneous behaviors (e.g., blushing during public speaking;
Implicit and Explicit Self-Esteem in Depression and Anxiety
PLOS ONE | DOI:10.1371/journal.pone.0166116 November 15, 2016 2 / 18
zonmw.nl/en/) and participating universities (VU
University Medical Center, Leiden University
Medical Center, University Medical Center
Groningen).
Competing Interests: The authors have declared
that no competing interests exist.
[10]). In support of this, Spalding and Hardin [11] found that those low in ISE, as indexed
with an affective priming task, displayed more observer-rated anxious behaviors during an
interview, specifically when the interview involved self-related questions. A more recent study
found that ESE was related to self-reported measures of anxiety/nervousness, and controlled
nonverbal behaviors during a speech (e.g., hand gestures to emphasize the point verbally
made), while ISE, as indexed by both a cognitive load task and the implicit association test
(IAT), was related to general observer-rated anxiety and spontaneous nonverbal behaviors
during a speech (e.g., nervous mouth movements; [10]). Given the distinct roles of ISE and
ESE in automatic and controlled dysfunctional (pathogenic) behaviors, it is feasible that these
two components of self-esteem are (partly) differentially involved in AD and MDD. As mea-
sures of ISE are thought to capture different aspects of the construct [12], it is important to
note which ISE measure has been used previously as this may explain inconsistencies in
findings.
Empirical evidence for the presence of low ISE in AD and MDD is mixed. Studies looking
at ISE in AD samples are relatively few and seem to have focused almost exclusively on social
anxiety disorder (symptoms). Two analogue studies using an IAT as a measure of ISE found
relatively low ISE in females scoring high on symptoms of social anxiety [13,14]. Consistent
with this, a correlational study focusing on adolescents showed a negative relationship between
symptoms of social anxiety and ISE measured with an IAT [15]. A more recent small-scale
clinical study found that patients with social anxiety disorder (n = 45) had lower ISE, as
indexed by an IAT, than healthy controls [16]. Patients with panic disorder (n = 24) showed a
similar tendency that was not significant, possibly due to low statistical power. Concerning
MDD, a meta-analysis of 25 studies (n = 2831, of which 77% non-clinical) indicated that there
is an association between low ISE and symptoms of depression [17]. However, when focusing
only on studies using clinical, adult depressed samples, many have failed to find lower ISE in
comparison to those who have never been depressed [18–21]. Risch et al. [22] did, however,
find lower ISE in current MDD patients (both first-onset and recurrent) compared to healthy
controls, when using an IAT. Franck, De Raedt, Dereu and van den Abbeele [23] also found
evidence for lowered ISE in current MDD patients using an IAT but only in those without sui-
cidal ideation, while MDD patients with suicidal ideation did not differ from never-depressed
controls. As such, despite the strong theoretical grounds for anticipating low ISE in MDD and
AD, the evidence thus far, particularly for MDD, is not very convincing, and suggest that dys-
functional self-related thoughts and behaviors may be most pronounced at the deliberate,
explicit level.
Previous studies involving clinical samples may simply not have had enough power to
detect an effect of ISE. Further, as little is known about ISE in comorbid MDD and AD, and
many studies looking at MDD do not have anxiety disorder diagnosis as an exclusion criterion
(e.g., [21,22]), it is important to look at ISE not only in comorbidity, but in (relatively) pure
forms of MDD and AD as well. This may elucidate the apparently inconsistent earlier findings
regarding ISE in MDD and AD. Therefore, the present study was designed in the context of a
large-scale, national study: the Netherlands Study of Depression and Anxiety (NESDA; www.
nesda.nl/). Specifically, ISE (and ESE) in (relatively) pure forms of MDD and AD, as well as in
individuals with comorbid MDD/AD were analyzed. Given previous reports of relatively high
reliability [12] with strong evidence of validity [10], the IAT was used to measure ISE. In addi-
tion, we took suicidal ideation into account to test the robustness of the earlier finding that
only in the absence of suicidal ideation is MDD associated with lowered ISE [23].
Given that low self-esteem is prevalent in both depression and anxiety, it seems feasible that
self-esteem is a transdiagnostic factor which may explain the high rates of comorbidity
between the two [24,25]. Indeed, low self-esteem may increase vulnerability for both
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depression and anxiety, and other factors may then determine, specifically, which of the two
develops. Consistent with this view, a relatively large scale study among non-referred adoles-
cents found that the association between symptoms of depression and social anxiety could
largely be explained by adolescents’ explicit self-esteem [15]. This earlier study provided no
evidence for a unique relationship between low self-esteem and the covariation of (social) anx-
iety and depressive symptoms, but rather independent relationships between low self-esteem
and the severity of depression and anxiety symptoms. This suggests that low self-esteem may
increase the chance of concurrent symptoms of anxiety and depression by independently
increasing the chance of developing both types of symptoms. Given that this earlier study was
limited to a non-clinical sample of adolescents, it remains to be seen whether self-esteem can
(partly) explain the high rates of comorbidity in an adult sample containing many who meet
the clinical criteria for a depression and/or anxiety disorder. Therefore, the relationship
between depressive and anxious symptoms are analyzed in the present study, once controlling
for self-esteem.
It is important to see to what extent low self-esteem will be normalized when remitted/
recovered from a depressive episode or anxiety disorder. Given the high rate of recurrence that
is typical of both MDD and AD, identifying possible “scars” that remain following episodes
(e.g., lowered ISE) may be crucial in identifying those who will relapse [26]. Even when AD
and MDD enters remission, or recovery, it is important to differentiate between ISE and ESE.
It is feasible that those who are in remission/recovery are able to address negative self-related
thoughts, and are motivated to reappraise a situation in order to derive at a more positive self-
evaluation. Indeed, self-awareness and addressing negative thoughts effectively is the core aim
of most therapies (e.g., cognitive behavioral therapy). However, given the lack of control over
ISE, spontaneous (pathogenic) behaviors may continue that are not necessarily within the
realm of awareness. Consistent with this, Vasey, Harbaugh, Buffington, Jones and Fazio [27]
found that implicit associations, as measured with an IAT, following an exposure therapy pre-
dicted return of fear in public-speaking phobia. Despite this, two studies reported that ISE and
ESE in remitted MDD did not differ from never-depressed controls, both of which had used
the IAT [18,22]. Given the small sample sizes used, it is important to test the hypothesis in
larger samples, and also take AD and comorbid MDD and AD into consideration as distinct
disorders with distinct etiologies. As ISE may improve over time through consistent high ESE
that becomes overlearned and the default reaction [28], it is also important to differentiate
between those whose symptoms have recently remitted and those who no longer meet the cri-
teria for MDD and AD for some time (recovered). The present study therefore included remit-
ted and recovered MDD, AD and comorbid MDD/AD groups.
For some individuals, ESE and ISE may differ considerably (i.e., discrepant self-esteem;
[29]). While fragile self-esteem refers to the pattern of low ISE and high ESE, and has been
linked to narcissistic tendencies [30], damaged self-esteem refers to the pattern of high ISE and
low ESE, and has been linked to symptoms of depression [31]. While some studies looked at
discrepancy by including the interaction between ISE and ESE into the model [32], others
argued that this fails to acknowledge the potential influence of the direction of the discrepancy
[33]. That is, the extent that ISE and ESE differ may only be related to symptoms of depression
or anxiety when, for example, ISE is higher than ESE. Without distinguishing the direction of
discrepancy, the interaction may appear statistically non-significant. Other studies looking at
self-esteem discrepancies adopted analyses that allowed for differentiating between the direc-
tion of the discrepancy (i.e., fragile or damaged), but did not allow for the inclusion of the
main effects (i.e., ESE and ISE; [34]). The inclusion of ESE into the model resulted in an issue
of multicollinearity. Given strong relationships between ESE and psychopathology are often
reported, previously observed associations between damaged self-esteem and depression may
Implicit and Explicit Self-Esteem in Depression and Anxiety
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have simply been an artefact of ESE, regardless of ISE. The final aim of the present study is
therefore to explore an alternative method to analyse the role of discrepant self-esteem in
MDD and AD which allows for differentiating between fragile and damaged self-esteem while
statistically controlling for the potential main effect of ESE.
All in all, the present study tested the following hypotheses: i) those without a lifetime diag-
nosis of depression or anxiety (i.e., the comparison group) will show higher ESE and ISE than
current MDD, AD, and comorbid MDD/AD; ii) ISE and ESE in the comparison group will
also be higher than those who were recovered or remitted from AD, MDD, or comorbid
MDD/AD; iii) those who have recovered or remitted from AD, MDD or comorbid both, will
have higher ISE and ESE than those who currently meet the diagnosis; iv) self-esteem is a
transdiagnostic factor, and as such, levels between MDD, AD and comorbid MDD/AD will
not differ at the remitted level, the recovered level and at the current diagnosis level. Further, a
novel way of testing the presence of self-esteem discrepancies in those with a current depres-
sion or current anxiety disorder is explored that allows for the inclusion of ESE as a main effect
in the model.
Materials and Methods
Participants
The Netherlands Study of Depression and Anxiety (NESDA; www.nesda.nl/) is an ongoing
longitudinal cohort study that, at baseline (2004–2007), involved 2981 participants who have
been followed-up biannually across a number of measures. In order to follow the long-term
course of depression and anxiety, 1701 participants with a current depressive or anxiety disor-
der, and 907 participants with a life-time diagnosis or at-risk (e.g., subthreshold symptoms),
were recruited from the community, primary care, and mental health organisations. A further
373 participants with no current or history of any depressive disorder or AD were recruited as
controls. There were two exclusion criteria in the NESDA: 1) A primary, clinically overt diag-
nosis of a psychotic disorder, an obsessive-compulsive disorder, a bipolar disorder, or a severe
addiction; 2) Non-fluent command of the Dutch language. A thorough overview of the recruit-
ment process, design, and overarching aims of NESDA are published elsewhere [35]. All par-
ticipants provided written consent, and ethical approval was granted by all ethical committees
of participating universities (VU University Medical Center, Leiden University Medical Center
and University Medical Center Groningen).
The present study makes use of data collected in the most recent wave at the time of writing,
which is approximately 6 years since baseline, and the fourth biannual measurement. At this
wave, 2256 participants were measured (24% attrition since baseline), where 1799 (80%)
received the measures relevant for the present analysis. The remaining 457 did not receive all
the measures for various technical reasons (e.g., completing measures at home or over the
phone prohibiting computer-based measures). Participants who were given all relevant mea-
sures were aged between 23 and 72 (M = 48.05, SD = 13.18; 63.6% female). Participants were
excluded from the present analysis if they had developed a bipolar disorder at some point dur-
ing the study, or reported an alcohol dependence since the last interview (approximately 2
years ago; n = 83).
Clinical groups were formed for MDD and AD, and split by those currently in an episode
(diagnosis in past month), those in remission (an episode that had ended in the last six—one
month), and those recovered (an episode in the last seven years–six months). We used these
cut-offs as these were more readily available within the study. It should be noted that what
defines, for example, a depression in remission varies across studies. Frank et al. [36] recom-
mends that remission be considered as a depression-free period of 2–6 months, with longer
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than 6 months considered a recovery. Our cut-offs are not too far from this. Cut-offs for ADs
are dependent on the type of AD, however we apply the same cut-offs as used for MDD for
consistency when comparing the groups and creating comorbid groups. To create a more
homogeneous group, participants were excluded from the current and remitted AD groups if
they had also met the criteria for MDD (or dysthymia; n = 135 & 27, respectively) since the last
interview. Likewise, those with an AD since the last interview were excluded from the current
and remitted MDD groups (n = 78 & 45, respectively). Those in the recovered AD or MDD
groups had no history of MDD (and dysthymia) or AD, respectively. Current and remitted
comorbid AD and MDD (CM) groups were also formed based on the same criteria as the
MDD and AD groups. Those who had comorbid dysthymia in the current CM and MDD
groups were not excluded. A recovered CM group was not created given that the available
information made it difficult to determine whether AD and MDD had occurred and ended at
the same time. The comparison (control) group consisted of individuals without a history of
AD, MDD or dysthymia. The upper half of Table 1 provides an overview of the demographics
and size of each group.
Measures
Beck Anxiety Inventory (BAI; [37]). The BAI is a self-report questionnaire measuring
the severity of 21 anxiety symptoms in the past week (e.g., “Nervous”, “Hot/cold sweats”). The
degree of botheration is answered on a 4-point Likert scale from 1 (Not at all) to 4 (Severely [I
could barely stand it]). Total scores were calculated (possible range: 21–84), with higher scores
indicative of relatively more anxious symptoms in the preceding week. Missing answers were
replaced with participant’s mean response (n = 47). From the 1799 participants, 29 participants
failed to return the questionnaire and four had more than nine missing answers; these were
excluded from any analysis involving the BAI. The BAI showed excellent internal reliability
across all those without missing answers (n = 2084; Cronbach’s α = .92).
Inventory of Depressive Symptomatology–self-report (IDS; [38]). The self-report IDS
was used to measure depressive symptomatology in the preceding seven days, based on the
Table 1. Means (& standard deviations; unless stated otherwise) of demographics and variables per group.
Major Depressive Disorder (MDD) Anxiety Disorder[s] (AD) Comorbid MDD & AD Comparison
Current
(n = 60)
Remitted
(n = 41)
Recovered
(n = 136)
Current
(n = 111)
Remitted
(n = 29)
Recovered
(n = 98)
Current
(n = 71)
Remitted
(n = 14)
Non-Clinical
(n = 382)
Age 49.05
(12.65)
49.02 (12.84) 46.95 (13.29) 48.85
(12.23)
45.45 (12.12) 47.56 (13.83) 46.90
(11.17)
44.93 (12.39) 48.23 (14.53)
Female
(%)
68.3 70.7 61.8 70.3 75.9 57.1 69.0 71.4 57.1
BAI 12.85
(8.04)
9.38 (6.09) 5.47 (5.15) 14.03 (9.63) 11.17 (8.24) 6.16 (4.79) 20.32
(10.17)
9.08 (6.65) 2.74 (3.48)
IDS 28.05
(9.82)
19.83 (7.51) 12.26 (8.99) 20.74
(10.59)
16.14 (8.45) 11.42 (7.01) 33.86
(10.85)
18.17 (8.16) 5.46 (4.74)
Invalid
IAT (n)
5 3 8 5 2 8 11 1 25
RSES 26.13
(5.24)e
27.71
(4.53)ed
32.45 (4.24)c 28.44
(5.11)ed
30.31
(5.23)cd
31.65 (4.57)c 23.07
(4.98)b
27.50
(3.88)ed
35.18 (3.98)a
IAT .62 (.47)ab .63 (.50)ab .65 (.45)a .61 (.44)ab .48 (.56)ab .64 (.47)a .41 (.47)b .54 (.41)ab .74 (.43)a
Note. BAI = Beck Anxiety Inventory; IDS = Inventory of Depressive Symptomatology; RSES = Rosenberg Self-Esteem Scale; IAT = Implicit Association
Test; Current = episode in the past month; Remitted = episode ended one–six months ago; Recovered = episode ended 6 months– 7 years ago.
For rows RSES and IAT: means with the same superscripts did not differ significantly (p > .05).
doi:10.1371/journal.pone.0166116.t001
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DSM-IV criteria for MDD. In the original version, at two points, participants can chose to
answer one of two items (e.g., “Decreased appetite” or “Increased appetite”), and therefore
answer 28 of the 30 items in total. The version in NESDA combines the paired items, and
therefore contains 28 items, all of which are answered by the participant. For each of the 28
items (e.g., “Feeling sad”) there are four corresponding answers from “0” that is indicative of
no depression (e.g., “I do not feel sad”) to “3” referring to a more severe depressive symptom
(e.g., “I feel sad nearly all the time”). A total score is derived (possible range: 0–84), and higher
scores are indicative of relatively severe depressive symptomatology. From the 1799 partici-
pants, 29 failed to return the questionnaire and three had too many missing answers (>6
items); these were excluded from any analysis involving the IDS. The IDS showed excellent
internal reliability across all those without missing answers (n = 2150; Cronbach’s α = .90).
Composite International Diagnostic Interview v2.1 (CIDI; [39,40]). Depressive and
anxiety disorders were determined using the semi-structured CIDI (v2.1). The CIDI is used
worldwide and WHO field research has found high inter-rater reliability [41], high test-retest
reliability [42], and high validity for depressive and anxiety disorders [40,43]. Diagnosis of
MDD, dysthymia, panic disorder (with and without agoraphobia), generalized anxiety disor-
der, social anxiety and agoraphobia were determined based on the criterion outlined in the
DSM-IV. MDD episode severity was determined by the number of nine possible depressive
criteria met (including the two core symptoms). Number of previous MDD episodes was
asked at baseline when participants indicated a history of (or current) MDD. A total number
of MDD episodes was derived by adding the number of waves where an MDD episode was
reported to the number of previous MDD episodes reported at baseline. Age of onset at first
MDD/AD episode was also asked when participants reported an MDD or AD disorder since
the previous interview. Trained research staff conducted the interview.
Implicit Association Test (IAT; [44]). Implicit self-esteem was measured with a self-
esteem version of the computer-based IAT. The IAT is a word-sorting task where words are
presented from two target categories: I (I, myself, self, my, own) and other (other, you, they,
them, themselves); and two attribute categories: positive (meaningful, successful, important,
worthwhile, confident) and negative (worthless, unimportant, weak, failure, useless; translated
from Dutch). Following two practice rounds of ten trials, participants sorted positive- and I-
related words with the same key and negative- and other- related words with the other key
(pairing 1). This was repeated for two blocks of 20 trials. Participants then completed another
practice block of ten trials with only attribute words, although key allocation had been
swapped. Participants ended the task with two blocks of 20 trials where negative- and I- related
words (and other- and positive- related words) shared the same key (pairing 2). Reaction time
of the initial response and accuracy were recorded. The premise of the IAT is that the attribute
and target categories that are more strongly associated for the participant are easier to sort
when they share a key. A person with high implicit self-esteem is therefore expected to find it
easier to sort words when I and positive share a key than when I and negative share a key.
The IAT was scored based on the D4-measure [45]. First, trials with reaction times longer
than 10,000 ms were discarded. Reaction times on error trials were replaced with the mean of
the correct answers in that block with an added 600 ms error penalty. The mean reaction time
for pairing 1 was then subtracted from the mean reaction time for pairing 2, then subsequently
divided by the pooled standard deviation of both pairings to control for individual variation.
Higher scores were therefore indicative of a relatively fast response when categories “I “and
“Positive” share a key, thus indicating higher implicit self-esteem. Participants were excluded
from any analysis involving IAT scores when more than 10% of trials were faster than 300 ms,
an error rate of over 20%, or where more than 1% of trials were longer than 10,000 ms
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(n = 114; [46,47]). Spearman-Brown corrected correlation between test halves was .85 (test
halves based on trials 1, 2, 5, 6, etc., and 3, 4, 7, 8, etc.).
Rosenberg Self-Esteem Scale (RSES; [48]). Explicit self-esteem was measured with a self-
report questionnaire containing 10 items answered on a 4-point Likert scale from 1 (strongly
agree) to 4 (strongly disagree). Higher scores (possible range: 0–40) were indicative of more
positive self-esteem. The measure showed good internal reliability in the present study (Cron-
bach’s α = .92; based on all 1799 participants).
Scale for Suicide Ideation (SSI; [49]). The first five items from the original 19-item SSI
were included in NESDA. These items were initially used as a screening instrument to identify
those who had active or passive suicidal ideation before receiving the rest of the questions to
gain further insight into the severity and attitudes of the suicidal ideation. The first five ques-
tions (e.g., “What feelings did you have last week about dying. Did you want to die and how
strong was this wish”) were asked in a semi-structured interview with answers given on a three
point scale, where 0 indicated no suicidal ideation and 2 indicated moderate to strong suicidal
ideation.
A dichotomous variable was created to identify those with suicidal ideation (1) and those
without (0) in the current MDD group. Suicidal ideation was quantified by a score above zero
on the SSI and on item 18 of the IDS [50]. Participants who scored 0 on both were identified as
not having suicidal ideation. Those who scored a zero on one measure, and higher on the
other, were excluded from the analysis.
Procedure
NESDA assessments take between three and five hours, and are completed in one sitting [35].
Assessments contain computer tasks, self-report questionnaires, interviews, and biological
measures carried out by trained staff. In all cases, participants completed the RSES after the
IAT. Participants received travel expenses and a 15 euro gift certificate.
Statistical Analysis
In the first part of the analysis, a MANOVA was conducted with RSES and IAT scores as
dependent variables, and group as the independent variable (current MDD, remitted MDD,
current AD, remitted AD, current CM, remitted CM, recovered MDD, recovered AD or con-
trols). Univariate extreme outliers in RSES and IAT scores, per group, were standardized val-
ues exceeding ±3.3 and omitted when present. In order to test for multivariate outliers,
Mahalanobis distance was calculated by regressing participant ID number onto RSES and IAT
scores for each group. With 2 degrees of freedom, and a critical alpha of .001, the critical chi-
square value was 13.82. Mahalanobis values exceeding this were excluded from the MANOVA
as they were considered multivariate outliers. Homogeneity of variance-covariance matrices
was checked using Box’s M. According to Tabachnick and Fidell, robustness is not guaranteed
when sample sizes are unequal and Box’s M test is significant at p< .001. We reported Pillai’s
Trace for the multivariate tests, and conducted Sidak comparisons to adjust for multiple test-
ing. Cohen’s d, unadjusted for the multiple testing, is reported for each significant comparison
to give an indication of the effect size and as such, reported p-value (adjusted for multiple test-
ing) and CI for the Cohen’s d (not adjusted for multiple testing) may differ (e.g., the latter may
contain a zero while the give p-value is significant). Comparisons between explicit self-esteem
scores were conducted on means slightly different than those reported in Table 1 given that a
number of participants had been excluded from the analysis based on invalid IAT scores.
In the final part of the analysis, looking at discrepant self-esteem (i.e., the extent that ISE
and ESE differ), two logistic regressions were conducted: current MDD group (vs. controls),
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and current AD group (vs. controls). The absolute difference between standardized scores of
the IAT and RSES were computed for all participants. Two discrepant self-esteem variables
were created: damaged self-esteem and fragile self-esteem. The damaged self-esteem variable
was computed by taking the absolute difference when IAT was higher than RSES; a 0 was
assigned for participants where RSES is higher than IAT. Likewise, the fragile self-esteem vari-
able was computed by taking the absolute difference when RSES was higher than IAT; a 0 was
assigned for participants where the reverse was true. As such, for each participant, an absolute
difference score appeared in either the damaged self-esteem variable or the fragile self-esteem
variable, and had a score of 0 in the other discrepant self-esteem variable. The two discrepant
self-esteem variables were entered at step one, with raw score on the RSES entered at step two.
Results
Missing Data Analysis & Descriptives
In order to check whether those who had received the self-esteem measures (i.e., completers,
n = 1799) were not systematically different from those who had not (i.e., non-completers,
n = 457), comparisons were made on BAI, IDS, and age. There was no evidence that the mean
age of non-completers (M = 46.81, SD = 12.80) differed from completers (M = 48.05, SD =
13.18), t(2254) = 1.81, p = .07, d = -0.09, 95% CI [-0.20, 0.01]. Scores on the BAI and IDS were
significantly positively skewed for both groups, and thus square-rooted (mean raw scores
reported for interpretability). Results based on equal variances not assumed suggested that
non-completers had higher BAI scores than completers (M = 8.40, SD = 9.64 versus M = 7.43,
SD = 7.95), t(518.02) = 4.57, p< .001, d = 0.28, 95% CI [0.17, 0.39], and higher IDS scores
(M = 17.95, SD = 13.85 versus M = 14.52, SD = 11.31), t(516.93) = 4.04, p< .001, d = 0.25, 95%
CI [0.13, 0.36].
Means and standard deviations of the various outcome and predictor variables are given in
the lower half of Table 1. Transformations did not correct data skew for IAT, RSES, BAI and
IDS scores (Shapiro Wilk’s > .97, p’s< .001) in the complete sample, and therefore Spear-
man’s Rho is reported. There was a small but statistically significant positive correlation
between ISE and ESE, ρ(1600) = .18, p< .001. Further, there were small but statistically signifi-
cant negative associations between ISE and symptoms of anxiety, ρ(1570) = -.09, p = .001, and
depression, ρ(1572) = -.12, p< .001, which disappeared once statistically controlling for ESE,
ρ(1569) = .02, p = .55 and ρ(1571) = .01, p = .78, respectively. ESE was strongly correlated with
symptoms of anxiety, ρ(1684) = -.55, p< .001, and symptoms of depression, ρ(1685) = -.67,
p< .001. Anxiety and depression symptomatology were also highly correlated, ρ(1682) = .78,
p< .001. This correlation decreased once controlling for ESE, r(1681) = .68, p< .001, and
barely changed once controlling for ISE, r(1568) = .77, p< .001.
Within the current MDD group, 29 participants indicated no suicidal ideation and 14 did.
Seventeen were excluded based on inconsistent answers on the SSI and the suicide-related
item on the IDS. An independent samples t-test indicated that those with suicidal ideation
reported lower ESE (M = 23.86, SD = 5.01) than those without (M = 28.17, SD = 5.13), t(41) =
2.60, p = .01, d = -0.85, 95% CI [-1.53, -0.16]. Excluding 5 with invalid IAT scores, there was no
evidence of a difference in ISE between those with suicide ideation (M = .68, SD = .61) and
those without (M = .54, SD = .40), t(36) = .81, p = 0.42, d = -0.29, 95% CI [-1.02, 0.44]. Those
with suicidal ideation (M = 35.71, SD = 10.78) did report substantially more depressive symp-
toms than those without (M = 23.00, SD = 7.20), t(41) = 4.59, p< .001, d = -1.50, 95% CI
[-2.23, -0.76].
To explore differences in self-esteem between types of AD, two one-way ANOVAs were
conducted. Differentiating between social anxiety disorder (n = 35), panic disorder (with or
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without agoraphobia; n = 21), agoraphobia (n = 26), and general anxiety disorder (n = 9), par-
ticipants from the current AD groups were excluded if another AD was present in the previous
six months (i.e., comorbidity within AD). Results indicated that while there was no evidence
of a difference in ISE, F(3, 82) = 0.05, p = .98, partial η2 = 002, there was a difference in ESE, F
(3, 87) = 5.00, p< .01, partial η2 = .15. Post-hoc t-tests (applying a Bonferroni corrected α =
.008) indicated that those with a social anxiety disorder (M = 26.80, SD = 4.56) had lower ESE
than those with panic disorder (M = 30.90, SD = 4.29), t (54) = 3.34, p = .002, d = -0.92, 95%
CI [-1.50, -0.34], and those with agoraphobia (M = 30.31, SD = 4.23),t (59) = 3.06, p = .003, d =
-0.79, 95% CI [-1.33, -0.26]). There was no evidence of further differences between AD types.
Differences in Self-Esteem between Clinical Groups and Controls
A MANOVA following the exclusion of two extreme univariate outliers revealed a Box’s M
that did not exceed the critical cut-off point of .001 (p = .03). The multivariate test was signifi-
cant suggesting an overall difference in self-esteem across groups, F(16,1726) = 30.36, p<
.001, partial η2 = .22. This was true for both ISE, F(8,863) = 4.95, p< .001, partial η2 = .04, and
ESE, F(8, 863) = 80.91, p< .001, partial η2 = .43. Sidak comparisons suggested that those in the
control group had significantly higher ISE than those in the current CM group (p< .001,
d = 0.78, 95% CI [0.50, 1.06]), but with no evidence that it was higher than those in the remit-
ted CM group, p = .98, d = 0.48, 95% CI [-0.07, 1.04]. Those who had recovered from MDD or
AD also reported higher ISE than those in the current CM group (p’s = .02, d’s = 0.54, 95% CI
[0.22, 0.85] & 0.58, 95% CI [0.25, 0.92], respectively). There was no evidence that those in the
control group differed in ISE from those in the current AD group, p = .15, d = 0.32, 95% CI
[0.11, 0.55], nor from those in the remitted AD group, p = .12, d = 0.59, 95% CI [0.20, 0.99].
There was no evidence of further differences in ISE between the control group and the other
clinical groups, nor between the clinical groups (p’s> .21). For ESE, the control group had sig-
nificantly higher levels than all the current, remitted and recovered groups (p’s< .01, d’s =
0.66–2.95). Further, those who had recovered from MDD and those who had recovered from
AD had higher ESE than all remitted and current groups (p’s< .05, d’s = 0.70–2.12) with the
exception of remitted AD (p’s = .46 & .99, respectively). There was no evidence of a difference
in ESE between those who had recovered from MDD and those who had recovered from AD,
p = .99, d = 0.19, 95% CIs [-0.08, 0.46]. Further, those with a current CM had lower ESE than
all MDD and AD groups (i.e., remitted & current; p’s< .01, d’s = 0.70–1.43), and lower than
those remitted from CM (p = .02, d = -0.92, 95% CI [-1.55,- 0.29]). Finally, those with a current
MDD reported lower ESE than those with a remitted AD (p = .01, d = 0.72, 95% CI [-1.20,
-0.24]). There was no evidence of further differences between the clinical groups (p’s>.19).
Discrepant Self-Esteem
A two-step logistic regression was conducted to see whether discrepant self-esteem (step one)
would predict current MDD from controls, and whether this would remain once including
ESE (step two). In the control condition, 238 participants had fragile self-esteem (e.g., stan-
dardized RSES>IAT) and 119 had damaged self-esteem (e.g., standardized IAT>RSES). In
participants with a current MDD, 15 had fragile self-esteem and 40 had damaged self-esteem.
Correlations between ESE and fragile self-esteem, r(410) = .51, p< .001, and ESE and damaged
self-esteem, r(410) =.-66, p< .001, were high but not multicollinear. Following the exclusion
of eight extreme outliers, 88.4% of the participants would have been predicted accurately based
on chance alone (i.e., a model without predictors). This accuracy increased to 90.3% (Nagelk-
erke’s R2N = .29) with the inclusion of absolute discrepancy for damaged self-esteem,
Wald = 21.11, p< .001, OR = 3.03, and the absolute discrepancy for fragile self-esteem,
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Wald = 5.33, p = .02, OR = .32). With the inclusion of RSES scores, the accuracy increased to
93.1% (Nagelkerke’s R2N = .63). There was no evidence that damaged self-esteem, Wald = .09,
p = .77, OR = .91, or fragile self-esteem, Wald = .09, p = .76, OR = 1.17, contributed signifi-
cantly to this model. ESE was a significant coefficient, suggesting relatively higher levels
decreased the odds of current MDD, Wald = 44.51, p< .001, OR = .60.
A similar two-step logistic regression was conducted to differentiate current AD from con-
trols. In participants with a current AD, 40 participants had fragile self-esteem and 66 had
damaged self-esteem. Correlations between ESE and fragile self-esteem, r(461) = .52, p< .001,
and ESE and damaged self-esteem, r(461) = -.65, p< .001, were high but not multicollinear.
Following the exclusion of eight extreme outliers, a model without predictors had an accuracy
of 78.5%. This accuracy increased to 79.8% with the inclusion of the discrepancy self-esteem
variables (Nagelkerke’s R2N = .18). Both damaged self-esteem, Wald = 18.20, p< .001, OR =
2.37, and fragile self-esteem, Wald = 6.69, p = .01, OR = .55, were significant predictors. With
the inclusion of RSES scores in the model, the accuracy increased to 85.9% (Nagelkerke’s
R2N = .53). Neither damaged self-esteem, Wald = 1.51, p = .22, OR = .73, nor fragile self-esteem,
Wald = .72, p = .40, OR = 1.26, showed evidence of being significant determinants in the
model. RSES scores was a significant determinant, Wald = 78.26, p< .001, OR = .64, suggest-
ing that a relatively high ESE considerably reduced the odds of being in the current AD group.
Discussion
The key findings of the present study were: i) Implicit self-esteem was lower in current comor-
bid individuals compared to a healthy comparison group; ii) Explicit self-esteem was lower in
all current, remitted, and recovered clinical groups than the healthy comparison group; iii)
Explicit self-esteem in current MDD and AD was not lower than in remitted MDD and AD,
respectively. However, self-esteem was lower than in recovered MDD and AD. iv) There was
no support for discrepant self-esteem in current MDD and current AD, once statistically con-
trolling for explicit self-esteem.
Previous studies have consistently found lowered ESE in individuals with MDD and AD
[1,2]. It is not particularly surprising that current MDD had lower ESE in both previous studies
and the present study given that low ESE is a possible symptom of MDD. Despite this, ESE
was not lower in MDD than in AD, where low self-esteem is not a symptom per se. This may
highlight low self-esteem as a transdiagnostic factor explaining why comorbidity between
depression and anxiety is so high [24]. Some argue that depression and self-esteem have over-
lapping causal factors, which may explain some of the shared variance. For example, Neiss
et al. [51] concluded that there was a common genetic and environmental influence on self-
esteem, negative emotionality and depression, based on stronger associations in monozygotic
twins, compared to dizygotic twins. In the present study, although self-esteem in current
MDD and current AD was similarly low, the correlation between symptoms of depression and
anxiety remained high when partialling out ESE. Although this is consistent with the findings
from a previous cross-sectional study [15], it need not mean that self-esteem does not increase
the risk of developing a comorbidity. A longitudinal design is required to see which aspects of
a current depression or anxiety, like low self-esteem, is related to increased risk for comorbid
anxiety and depression, respectively. Highlighting which symptoms to target first to prevent
comorbid disorders from developing may be particularly important given that comorbid AD/
MDD is more persistent and treatment-resistant than purer forms of MDD and AD [52].
Despite the indisputable presence of low ESE in AD and MDD, how it relates to anxiety
and depression remains an important question. Low self-esteem has also been argued to have a
causal role in the development of AD and MDD, as lower levels are often observed to precede
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symptomatology [4]. Through social disruptions, increased self-focus, rumination, and lack of
ability to negate or minimize the effects of anxious or threatening thoughts and feelings, low
self-esteem could make a person more vulnerable to the development of AD and MDD symp-
tomatology [4,5]. This may explain why those with social anxiety disorder had lower ESE than
both panic disorder and agoraphobia, given both the social-related aspects and feelings of anxi-
ety that may arise in low self-esteem. Interventions that focus specifically on increasing self-
esteem might prevent both MDD and AD from developing. For example, in competitive mem-
ory training, positive self-images are made more salient and therefore increases the likeliness
that the positive self-image is activated when the self is brought to attention. This intervention
was found to improve self-esteem and depressive symptomatology in addition to treatment as
usual in patients with MDD [53], but it remains to be seen whether it can also be used in pre-
vention. Given the nature of self-report measures (e.g., the awareness that answers will be seen
by someone else), negative self-evaluations are purposefully self-endorsed in MDD and AD,
self-esteem interventions should not only aim to change the content of self-related evaluations
but also aim to learn how to oppose negative self-evaluations that arise.
ISE in relatively pure MDD and AD was found not to differ from controls. In other words,
self-related negative thoughts occur when purposefully thought about, whereas negative self-
associations do not already arise at the automatic and reflexive level. For MDD, this does not
appear to be explained by the presence (or absence) of suicidal ideation as was found in a pre-
vious study [23]. The lack of low ISE in MDD is consistent with many findings (e.g., [20]) but
conflicts with Risch and colleagues [22]. Given that the same measure of ISE was used, explain-
ing the conflicted findings is not straightforward. As we found lower ISE in the current CM
group, the presence of AD in the MDD group may account for the lower ISE observed in their
study. In the previous study where low ISE was observed in individuals with social anxiety dis-
order (n = 33), 40% also reported a comorbid depressive disorder [16]. Although in this earlier
study a comparison of those with and without a depressive disorder suggested no difference in
ISE, the small sample sizes may have limited the power to detect an effect. Previously reported
low ISE in AD as well as MDD might be explained by the unaccounted presence of comorbid-
ity. Then together with the numerous previous cross-sectional studies using clinical popula-
tions where no difference in ISE was found [20], one would be tempted to conclude that low
ISE is not a feature of pure AD and MDD. However, if ISE is formed following prolonged peri-
ods of ESE that becomes overlearned, as argued by many (e.g., [8]; although see [54]), the low
ESE prevalent in MDD and AD should eventually manifest in lower ISE. Another assumption
of this dual processing model, is that the level of ESE is stable, before it becomes overlearned
and automatic [28]. However, highly unstable ESE has been argued to be a larger vulnerability
factor for MDD and AD than consistently low ESE [55,56]. As such, if ESE is particularly
unstable in MDD and AD, then this may also explain why the findings involving ISE are rela-
tively inconsistent.
The role of prolonged low ESE in the development of low ISE may explain why low ISE was
observed in comorbid AD and MDD. There is some indication that the duration of symptom-
atology in CM would be longer given that remission rates for CM between baseline and two-
year follow-up in NESDA were a lot lower, and more months with symptomatology were
reported, than those with either MDD or AD alone. This is despite those with CM were more
likely to seek treatment.[52]. Prolonged periods of MDD and AD might give rise to longer
periods of (stable) low ESE, and this in turn might explain why lower ISE was observed in CM
only. Future studies looking at the duration, severity, and stability of low self-esteem, should
look at whether the duration of symptoms in current clinical groups is associated with low ISE.
Alternatively, more frequent measures of ESE over a period of time might be a more precise
way of looking at the role of ESE in ISE, and could also be used to look at the role of self-esteem
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stability in clinical disorders [57]. Untargeted negative self-evaluations at the implicit level
may also explain why those with CM are more likely to show a poorer response to treatment
(e.g., [58]). Concerning self-esteem scars in those with a previous MDD and/or AD, ISE was
not lower in remitted and recovered AD/MDD in comparison to controls. However, this is
perhaps unsurprising given that current AD and MDD also did not display lower ISE. ESE in
participants with a previous MDD or AD was significantly lower than those who had never
had a MDD or AD. This might partially explain the highly recurrent nature of both disorders
given that low ESE is argued to increase the vulnerability for symptomatology [4], and may
suggest the need for a self-esteem intervention in those who have recently recovered or remit-
ted from AD or MDD. Interventions for remitted MDD, in general, have been shown to be
effective in reducing relapse risk [59].
Damaged self-esteem increased, while fragile self-esteem decreased, both the likelihood of
current MDD and current AD, compared to controls. This is consistent with previous findings
[31], although we extend this by highlighting that discrepant self-esteem variables were no lon-
ger significant once controlling for the main effect of ESE. Previous methodology either did
not allow for the inclusion of ESE in the model [31,33], or did not allow for the specification of
the direction of discrepancy (i.e., using the interaction between ISE and ESE to represent dis-
crepancy). Although the current methodology allows for the inclusion of one main effect, it
does not allow the direction of the discrepancy to be taken into account (i.e., damaged vs. frag-
ile) regardless of the extent of discrepancy which has been argued to be an important factor in
discrepant self-esteem [33]. However, the relevance of such a variable is debatable. Even if one
were to select only those with discrepant self-esteem (i.e., excluding those with fairly congruent
self-esteem), it is theoretically still anticipated that a relatively large discrepancy in one specific
direction would have a stronger association with symptomatology compared to a smaller dis-
crepancy within the same direction. Therefore, the method used in the present study not only
allows for the inclusion of one main effect, but also eradicates variables that are difficult to
interpret.
Although we feel that the method used in the current study is an improvement, there are
still a number of limitations. In using the IAT and RSES to derive at measures of discrepancy
there is an assumption that the two measures only differ on the construct they tap into. How-
ever, the RSES refers to explicit self-esteem in the past seven days, while in the IAT self-esteem
is measured at that specific moment. Further, although ISE is anticipated to be a trait rather
than a state, it is also argued to be context-dependent. As such, the lab settings may have an
influence. For ESE, participants are able to reflect to more natural, daily situations. As such,
not just a difference in timing, but also a difference in context might be measured. Ideally, a
measure would be developed that directly taps into self-esteem discrepancy. We do not reject
the notion of discrepant self-esteem, necessarily, but current methods (present study includ-
ing) of combining ISE and ESE measures may introduce too much noise for quantifying real
discrepancies.
Limitations
Little can be said about the causal relationship of self-esteem in MDD and AD given the corre-
lational and cross-sectional design of the present study. As low ESE was prominent across
most clinical groups, the next logical step would be to study whether manipulating self-esteem
influences symptomatology. There is some support that this may be the case given that self-
esteem interventions also showed beneficial effects on symptoms of depression and anxiety
[53]. However, it is also theoretically feasible that low self-esteem is the by-product of symp-
toms. Experience sampling might be a more elegant way of looking at whether self-esteem
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precedes symptoms or symptoms precedes self-esteem, particularly as many studies argue that
self-esteem fluctuates on a daily basis in response to negative and positive events [60].
Even within the large scale NESDA study, both remitted AD (n = 29) and remitted comor-
bidity (n = 14) had comparatively small groups, and therefore the possibility to detect an effect
may have been limited. Small clinical samples are relatively common in research [19,22]
because, for example, recruitment can be difficult (especially if one needs relatively “pure”
groups), and drop-out rates are high. The power to detect a difference between remitted
comorbidity (i.e., the smallest group) and the healthy comparison group was 83% for a large
effect (.80), 45% for a medium effect (.50) and 11% for a small effect (.20) [61]. As such, there
was limited power to detect medium and small effects, which may have resulted in type II
errors. However, the limited sample size is unlikely to have inflated the Type I error. Future
studies need to focus on recruiting larger samples of remitted AD and remitted comorbidity,
as these, particularly, were underpowered in the present study.
There are a number of critics of the IAT, and other measures of ISE. Many criticisms con-
cern the lack of applicability with regards to using cut-off scores (e.g., above a specific score is
indicative of an implicit racial bias; [62]. However, even when comparing scores on the IAT
between groups, as in the present study, a number of criticisms remain relevant. One of the
more recent criticisms concerns the inability for the IAT to highlight how attributes and tar-
gets are related (e.g., differentiating between implicit ideal self and actual self [63]). Despite
promising findings in differentiating between ideal self and actual self in dysphoric students
[63], research is needed to justify the notion of implicit goal-oriented constructs (i.e., construct
validity of implicit ideal self). Also given the relatively more obvious nature in the way it was
measured (i.e., “I am” and “I want to be” remained onscreen during the word-sorting task), it
is unclear in how far this may have triggered explicit processing thereby influencing the speed
with which words were sorted. Further criticism comes from the low validity of ISE measures,
which have led some to doubt whether ISE actually exists. One common argument stems from
the validity of ISE measures in comparison to the validity of ESE measures (e.g., [64,65]).
Validity of ESE measures is likely to be overinflated given that biases and measurement error
is likely to apply to all measures of ESE (i.e., inflated convergent validity), and is likely to apply
to self-report measures of other constructs (i.e., inflated predictive validity). For example, self-
enhancement bias is not only, presumably, going to affect all self-report measures of ESE, but
also self-report measures of depressive symptomatology. As such, it is unsurprising that self-
report measures of ESE often trump implicit measures of ISE. Another line of criticism regard-
ing IAT and ISE seems to stem from the conceptual misunderstanding that a single self-esteem
exists which can be accessed implicitly or explicitly. Doubts are then voiced because of the lack
of correlation between ISE and ESE measures which is often lower than other implicit and
explicit constructs [66]. However, theories postulate that ISE is best considered as the most
primitive self-evaluation. With increasing time, cognitive resources and motivation, other pro-
cesses are activated that may alter, overrule, or support the initial reaction. Indeed, when
encouraged to rely on their gut-feeling (i.e., intuition), correlations between ESE and ISE
increase [67]. There are many possible reasons as to why ESE does not correlate with ISE (e.g.,
self-enhancement bias, self-protection bias, narcissism), and not all apply to other implicit/
explicit constructs. This is why correlations between the two are often reported to be very
small or non-existent, and may explain why correlations in other implicit/explicit constructs
are higher [66]. ISE is likely to be considered to contain more truth value in a person who val-
ues their “intuition” or “gut feeling” highly, or does not have the cognitive resources to carry
out ESE elaborately, in which ISE evaluations may carry more weight. Undeniably, the IAT is
no perfect measure of ISE, and our understanding of ESE and ISE certainly requires further
refinement. However, previous research has demonstrated the IAT to have high validity
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[10,11,68] and reliability [12,45] and as such, completely discarding the IAT as a measure of
ISE is not entirely justified.
Conclusions
The present study was the first to compare levels of both ESE and ISE across various phases of
MDD and AD groups and with careful consideration of comorbidity. We found that consis-
tent across all clinical groups, at all phases, a more negative, self-evaluation was endorsed in
comparison to the control group. In other words, conscious behaviour consistent with low
ESE is more likely to manifest in MDD and AD, and remain during remittance and recovery.
However, negative self-evaluations at the implicit level were only evident in individuals with
current CM, while levels of ISE in relatively pure forms of MDD and AD were equivalent to
the controls. This may not only highlight why CM is more persistent and treatment-resistant,
but also emphasizes the need for future research to investigate whether the aetiology of CM
differs from MDD or AD. As such, it is also important to control for the potential presence of
a comorbid disorder when further examining the relevance of ISE (and ESE) in AD or MDD.
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